{
    "Clinical Trial ID": "NCT03202472",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Diagnostic (Radiofrequency-guided Localization)",
        "  Patients undergo mammogram or ultrasound for image-guided placement of the radiofrequency tag within 30 days of surgery and then undergo radiofrequency-guided localization during surgery.",
        "  Implanted Medical Device: Radiofrequency tag",
        "  Mammography: Undergo mammogram for image-guided placement of radiofrequency tag",
        "  Questionnaire Administration: Ancillary studies",
        "  Radiofrequency-Guided Localization: Undergo radiofrequency-guided localization",
        "  Ultrasonography: Undergo ultrasound for image-guided placement of radiofrequency tag"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Able to give written informed consent to participate in the study",
        "  Able to read and write English",
        "  Patients with breast lesions that are non-palpable that require surgical removal",
        "  Lesions and/or clip targetable with image guidance",
        "Exclusion Criteria:",
        "  Multicentric breast cancer",
        "  Stage IV breast cancer",
        "  Pregnant or lactating females"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Patients With Successful Placement of the Radiofrequency Tag Under Radiographic Guidance Confirmed by Mammography",
        "  Patients with successful radiofrequency tag placement",
        "  Time frame: at time of device placement, confirmed by mammography",
        "Results 1: ",
        "  Arm/Group Title: Diagnostic (Radiofrequency-guided Localization)",
        "  Arm/Group Description: Patients undergo mammogram or ultrasound for image-guided placement of the radiofrequency tag within 30 days of surgery and then undergo radiofrequency-guided localization during surgery.",
        "  Implanted Medical Device: Radiofrequency tag",
        "  Mammography: Undergo mammogram for image-guided placement of radiofrequency tag",
        "  Questionnaire Administration: Ancillary studies",
        "  Radiofrequency-Guided Localization: Undergo radiofrequency-guided localization",
        "  Ultrasonography: Undergo ultrasound for image-guided placement of radiofrequency tag",
        "  Overall Number of Participants Analyzed: 50",
        "  Measure Type: Count of Participants",
        "  Unit of Measure: Participants  50 100.0%"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/50 (0.00%)"
    ]
}